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Introduction:  Intussusception,  an  abdominal  emergency  in  young  children,  has  been  linked to  a  previous
vaccine  used  to prevent  rotavirus  gastroenteritis.  Although  this  vaccine  was withdrawn,  recent  studies
have  suggested  a potential,  very  small  increased  risk  of  intussusception  following  the  administration  of
newly  developed  rotavirus  vaccines.  We  aimed  to  determine  the  baseline  incidence  of  intussusception
among  infants  in  the  UK  and  Republic  of  Ireland  –  prior  to the  imminent  introduction  of  the  rotavirus
vaccine  into  the  UK  schedule  this  year.
Methods: Prospective,  active  surveillance  via  the established  British  Paediatric  Surveillance  Unit  (BPSU)
was  carried  out  from  March  2008  to  March  2009.  Clinicians  across  101  National  Health  Service  (and
equivalent)  hospitals,  including  27  paediatric  surgical  centres,  reported  cases  admitted  for  intussuscep-
tion  in  the  UK  and  Republic  of  Ireland.  The  standard  Brighton  Collaboration  case  deﬁnition  was  used  with
only  deﬁnite  cases  included  for  incidence  estimation.
Results: The  study  response  rate  was  94.5%  (379  questionnaires  received  out of  401 case  notiﬁcations).  A
total  of  250  deﬁnite  cases  of  intussusception  were  identiﬁed.  The  annual  incidence  among  infants  in  the
UK  and  Republic  of  Ireland  was  24.8  (95%  CI: 21.7–28.2)  and  24.2  (95%  CI:  15.0–37.0)  per  100,000  live
births.  In the  UK,  the  highest  incidence  occurred  in  Northern  Ireland  (40.6, 95%  CI:  21.0–70.8),  followed  by
Scotland  (28.7,  95%  CI: 17.5–44.3),  England  (24.2,  95%  CI: 20.9–27.9),  then  Wales  (16.9, 95% CI:  6.8–34.8).
In  England,  regional  incidence  was  highest  in  London  and  lowest  in the  West  Midlands.  By  age,  the highest
incidence  (50.3/100,000  live  births,  95%  CI: 33.4–72.7)  occurred  in  the  ﬁfth  month  of life  (for  England).
A  seasonal  trend  in  the presentation  of  intussusception  was  observed  with  the  incidence  signiﬁcantly
(p  =  0.001)  increased  during  winter  and  spring.
Conclusion: The  baseline  rates  obtained  in  this  study  will  inform  rotavirus  vaccine-safety  policy  by
enabling  comparison  with  post-introduction  incidence.. Introduction
Intussusception is the most common cause of acute bowel
bstruction in children aged less than two years [1,2]. The con-
ition was causally linked to a previous vaccine for preventing
otavirus gastroenteritis in infants [3], followed by withdrawal of
Abbreviations: BPSU, British Paediatric Surveillance Unit; NHS, National Health
ervice;  ONS, Ofﬁce for National Statistics.
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this vaccine from the routine immunisation schedule among US
infants in 1999 [4]. Subsequently, new rotavirus vaccines have been
developed and although initial studies did not show an increased
risk of intussusception [5,6], some evidence of a potential, very
small elevated risk has recently been found particularly after the
ﬁrst dose of these vaccines (possibly 2/100,000) [7,8]. However,
both these studies emphasised the strong evidence of protection
offered by these vaccines against rotavirus gastroenteritis – these
health beneﬁts as reﬂected by the number of deaths and hospital-
isations prevented from vaccination, substantially outweighed the
Open access under CC BY license.potential, very small number of intussusception cases that were
found to be attributable to vaccination [8].
To continue monitoring the safety of the newly developed
rotavirus vaccines, studies worldwide have estimated the baseline
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ncidence of intussusception in order to evaluate more rapidly any
dverse event reports following the introduction of these vaccines.
verall, studies in Europe and America have reported the baseline
ncidence in infants to be ≤60 cases per 100,000 [9–15]. This com-
ares to relatively higher rates (>60 to 302/100,000) reported from
ceania [16,17] including the Far East [18–22], with lower rates
<30/100,000) from south-east and central Asian countries [23,24].
Although genetic, dietary and environmental factors can place
ome infants at a higher risk for intussusception; a host of other
actors including differences in study methodology, availability
f diagnostic and specialist services, and access to these services
ight contribute to the observed variation in the global, baseline
ncidence.
Although developing countries face the greatest impact of the
urden of rotavirus diarrhoea in children under ﬁve [25,26], a large
umber of hospitalisations and clinic visits due to rotavirus infec-
ions occur in developed countries including the UK [27]. The UK
epartment of Health has recently announced the introduction of
 new rotavirus vaccine (Rotarix®; GSK vaccines) into the UK infant
mmunisation schedule in 2013. With an 85% efﬁcacy against severe
otavirus gastroenteritis [5], this oral vaccine which will be given
o infants in two separate doses with other routine vaccines, is pre-
icted to reduce the burden of severe rotavirus diarrhoea by 70% in
ngland and Wales [28].
The  only UK population-based study on intussusception was
arried out nearly twenty years ago (1993–1995) and used retro-
pective, routinely collected data for England [29]. This is the ﬁrst
rospective, nationwide surveillance study to determine the base-
ine incidence of intussusception in infants in the UK and Republic
f Ireland. The study further provides pre-vaccination rates by
onth of life including the association of seasonal patterns with
ntussusception.
. Methods
Prospective, active surveillance of intussusception presenting in
he ﬁrst year of life was carried out between 1st March 2008 and
1st March 2009. The established British Paediatric Surveillance
nit (BPSU) reporting system was used in joint collaboration with
he British Association of Paediatric Surgeons.
Inclusion criteria were infants admitted with suspected or con-
rmed intussusception during the study period in National Health
ervice (NHS) and equivalent hospitals across the UK and Republic
f Ireland, aged less than 12 months at the time of admission.
his was the ﬁrst BPSU study to involve paediatric surgeons in
ddition to the established participation of paediatricians in case
eporting.
The BPSU cards were sent monthly to paediatricians and paedi-
tric surgeons requesting them to notify cases of intussusception
eeting a standard case deﬁnition [30]. Clinicians were then con-
acted with a brief study questionnaire on the epidemiology and
linical features of intussusception for each notiﬁed case.
The  study response rate was based on the number of com-
leted questionnaires (including duplicates) returned by clinicians
s numerator and the total number of case notiﬁcations as denom-
nator. Duplicates were identiﬁed using the unique NHS number
or England and Wales. The Community Health Index, the Health
nd Social Care Number and patient/chart numbers along with date
f birth and gender were used to identify duplicates for Scotland,
orthern Ireland and Republic of Ireland.
Cases were then classiﬁed according to internationally agreednd validated Brighton Collaboration Criteria as deﬁnite (level 1),
robable (level 2) or possible (level 3) [31,32]. Statistical analyses
ere restricted to deﬁnite cases, and also excluded readmission
pisodes and overseas patients. (2013) 4098– 4102 4099
The  study was approved by the Wandsworth Research Ethics
Committee (reference 07/Q0803/62) and the National Information
Governance Board (PIAG/BPSU 2-5(FT1)/2007).
2.1. Statistical methods
Incidence  rates were calculated using deﬁnite cases as numer-
ator while the denominator was the total number of live births in
England, Wales, Scotland, Northern Ireland and Republic of Ireland
[33–36]. Incidence estimates were annualised and expressed per
100,000 live births with 95% conﬁdence intervals. Poisson regres-
sion models were ﬁtted to analyse variation in incidence across
English regions. GP surgery postcodes were used as a proxy for the
child’s residential address; these were also used to associate the
child to one of the nine English regions or other UK countries.
For  England, baseline rates were also obtained by month of life
using the number of deﬁnite cases (for each month) as numera-
tor. The denominator was obtained from the Ofﬁce for National
Statistics (ONS) by linking births and deaths using the NHS numbers
in the cohort of babies born in March 2008 and followed through
subsequent months.
Ethnicity  data (obtained from clinicians via case-notes) were
collected using a standard classiﬁcation [37]. The annual incidence
by ethnic group was calculated for England and Wales using the
ONS number of live births for each ethnic group (reported by
mother) as denominator.
To  study the possible effect of seasonality (of intussusception)
on incidence for the UK and Republic of Ireland, the number of
deﬁnite cases according to each admission month was used as
numerator and live births by month of occurrence (UK and Ireland)
as denominator. Cosinor models were used to analyse annual sea-
sonal patterns assuming that the monthly frequencies occurred at
mid-month [38].
SPSS  (version 17, SPSS Inc., Chicago, IL, USA) and the R com-
puting environment (version 2. 13.1, R Foundation for Statistical
Computing, Vienna, Austria) were used for statistical analyses.
3.  Results
A  total of 101 hospitals from all over the UK and Republic of
Ireland reported cases in this study. This included clinicians repor-
ting from 87 paediatric medical and 27 paediatric surgical units
(with some duplicate reporting from either different hospitals or
from paediatric medical and surgical units of the same hospital).
Of 401 cases notiﬁed to the BPSU, we  received 379 (94.5%) com-
pleted questionnaires (including 103 duplicate questionnaires).
The remaining 7 out of the 110 identiﬁed duplicates occurred at the
BPSU card notiﬁcation level (without any questionnaires returned
for these 7 cases). A total of 250 deﬁnite cases were thus obtained
for analyses after excluding 6 readmissions 4 overseas patients, 12
probable and 4 possible cases (Fig. 1).
Of 250 deﬁnite cases, nearing two-thirds (64.8%) of the cases
were boys with a male:female ratio of 1.8:1. The median age was
6.2 months (interquartile range: 4.2–8.5 months) with the most
frequent occurring age of 5.4 months. Among ethnic groups (243
cases with 7 missing), White British infants comprised the high-
est percentage (168/243, 69.1%) followed by Other White (28/243,
11.5%) and Black African (11/243, 4.5%) infants.
The annual incidence in the UK was  24.8/100,000 (95% CI:
21.7–28.2) and that of Republic of Ireland was 24.2/100,000 (95%
CI: 15.0–37.0). The highest incidence was  observed in Northern
Ireland followed by Scotland, England and then Wales. In England,
London showed the highest incidence while the lowest occurred
in the West Midlands region (Table 1). Using Poisson regression
and with London as reference category, incidence was  found to
4100 L. Samad et al. / Vaccine 31 (2013) 4098– 4102
401 case 
noﬁcaons
260 deﬁnites cases
250 deﬁnite cases 
(excludes  6 readmissio ns 
& 4 overseas cases)
12 probable cases 4 possible cases
110 Du pli catesa 15 non -responders
Fig. 1. Study proﬁle. aSeven duplicates identiﬁed at BPSU card level but question-
naires  were not returned for these 7 duplicate cases resulting in 103 (instead of
110) duplicate study questionnaires returned. These patients were initially notiﬁed
(via BPSU orange cards) by ≥2 paediatricians (from the same hospital) but only one
questionnaire was returned for each case.
Table 1
Annual incidence (95% CI) expressed per 100,000 live births – by English region/UK
country  and Republic of Ireland (n = 250).
Region/country Number of
deﬁnite
cases
Number of
live  births
Annual
incidence/100,000
live births (95% CI)
England 190 724,260 24.2 (20.9–27.9)
North East 6 32,318 17.1 (6.3–37.3)
North West 29 94,884 28.2 (18.9–40.5)
Yorkshire and Humber 16 71,566 20.6 (11.8–33.5)
East Midlands 11 58,362 17.4 (8.7–31.1)
West Midlands 13 77,366 15.5 (8.3–26.5)
East of England 27 76,996 32.4 (21.3–47.1)
London 51 137,806 34.2 (25.4–44.9)
South East 20 111,933 16.5 (10.1–25.5)
South West 17 63,029 24.9 (14.5–39.9)
Wales 7 38,235 16.9 (6.8–34.8)
Scotland 20 64,312 28.7 (17.5–44.3)
Northern Ireland 12 27,312 40.6 (21.0–70.8)
b
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Table 3
Incidence by ethnic group – England and Wales (n = 197).a
Ethnic group Number of
deﬁnite
cases
Number  of live
births  (by
ethnic group)
Annual
incidence/100,000
live births (95% CI)
White British 140 459,491 28.1 (23.7–33.2)
White Other 7 51,166 12.6 (5.1–26.0)
Asian – Indian 2 20,258 9.1 (1.1–32.9)
Asian – Pakistani 10 27,637 33.4 (16.0–61.4)
Asian – Bangladeshi 0 9522 0 (0–35.8)
Black Caribbean 5 7491 61.6 (20.0–143.8)
Black African 10 24,052 38.4 (18.4–70.6)
All Othersb 16 64,003 23.1 (13.2–37.5)
a
as Switzerland (56/100,000) and Germany (60.4/100,000) [9,10].
Consistent with these National studies, we  used the standard
Brighton Collaboration case deﬁnition for intussusception. We
undertook rigorous methods to exclude duplicates. However it isUK 229 854,119 24.8 (21.7–28.2)
Republic of Ireland 21 80,147 24.2 (15.0–37.0)
e signiﬁcantly lower for the South East (p = 0.005), East Midlands
p = 0.04) and West Midlands (p = 0.01), but not for the remaining
nglish regions (results not shown in Table 1).
Of 190 deﬁnite cases in England, the lowest incidence wasbserved in infants aged less than 2 months, after which the inci-
ence increased reaching a peak in the 5th month followed by an
verall decline in the 10th and 11th months of life (Table 2).
able 2
ncidence by month of life – England (n = 190).
Month of life Number of
deﬁnite  cases
Number of
live  births
Incidence/100,000
live births (95% CI)
<1 2 55,911a 3.6 (0.4–12.9)
1 2 55,733 3.6 (0.4–13.0)
2 15 55,688 26.9 (15.1–44.4)
3 26 55,657 46.7 (30.5–68.5)
4 17 55,647 30.6 (17.8–48.9)
5 28 55,642 50.3 (33.4–72.7)
6 24 55,634 43.1 (27.6–64.2)
7 16 55,627 28.8 (16.4–46.7)
8 21 55,625 37.8 (23.4–57.7)
9 25 55,622 45.0 (29.1–66.4)
10 8 55,619 14.4 (6.2–28.3)
11 6 55,616 10.8 (4.0–23.5)
a Live births in March 2008 (0 month) and remaining cohort (accounting for sub-
equent  cohort deaths), by month of occurrence.Missing: 7.
b All Others (for live births by ethnic group – England and Wales) include: Chinese,
Other  Asian, Other Black, Other, and all Mixed groups.
Annual baseline rates were obtained by ethnic group for England
and Wales (197/250 conﬁrmed cases, 7 missing). The annual inci-
dence among White British infants was 28.1 per 100,000 live births
(95% CI: 23.7–33.2). For the remaining ethnic groups, the numbers
were low with associated wide conﬁdence intervals (Table 3). Using
White British as reference category, Poisson regression analysis was
performed to compare baseline rates by ethnic group. The White
Other was  the only ethnic group, which was signiﬁcantly (p = 0.04)
different compared to White British infants (results not shown in
Table 3).
A  seasonal pattern in the presentation of intussusception in the
UK and Republic of Ireland was  observed with incidence signiﬁ-
cantly increasing during winter and spring (p = 0.001, Fig. 2).
4. Discussion
This is the ﬁrst study providing current baseline incidence of
intussusception prior to the introduction of the rotavirus vaccine
into the UK vaccine schedule.
The  baseline rates obtained for the UK (24.8/100,000) and
Republic of Ireland (24.2/100,000) were lower than those estimated
by other European countries with active surveillance systems, suchFig. 2. Incidence by month of admission – UK and Republic of Ireland (the dashed
line  indicates the predicted values from the cosinor model).
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ossible that the lower rates observed in our study might reﬂect
ome underreporting. There are other methodological differences
etween the studies; for example, we used deﬁnite cases only,
hereas in the Swiss study probable cases were also included for
ncidence estimation [9].
The monitoring of vaccine safety usually involves passive or
ctive surveillance. While underreporting can occur in active
urveillance systems which rely a lot on clinical interest and
nvolvement, underestimation is also possible in passive surveil-
ance systems due to coding/misclassiﬁcation errors or by not
ncluding study subjects treated in outpatient/short stay settings
9,11,12]. However, passive systems can also overestimate rates by
isclassifying cases, for example, including suspected only cases
hich have not been clinically conﬁrmed or which do not meet
tandard case deﬁnition criteria [11,17].
There was variation in rates by English region (from 34.2 in Lon-
on to 15.5 in West Midlands). There might be geographic and/or
nvironmental variation in incidence, but underreporting in a few
aediatric surgical centres could also explain the lower rates. A high
umber of paediatric surgical centres in some regions, for example
n London, with patient cross-over to/from nearby regions could
lso have contributed to the varying rates.
Consistent with previous research, the proportion of boys with
ntussusception was higher than girls and the median age of 6.2
onths fell within the described peak affected ages – the 4th–8th
onths of life [2,11,17,39,40]. The lowest incidence was  observed
n the ﬁrst two months followed by a peak (50.3/100,000 live births)
n the ﬁfth month of life (for England). Reasons for this ﬁnding may
nclude changes in feeding practices affecting the infant gut [41],
aturation of lymphoid tissue or a decline in maternal antibodies
gainst infectious agents possibly associated with intussusception.
long with previous research [11,40,42], these rates provide valu-
ble data to evaluate any age-related change in incidence following
he introduction of the rotavirus vaccine among infants in England.
Among ethnic groups in England and Wales, high incidence rates
ere observed in Black Caribbean and African infants. Although the
umbers were small and fell short of statistical signiﬁcance (except
or ‘Other White’) when compared to White British infants, our
nding is comparable to US studies in which signiﬁcantly higher
ncidence rates were observed in non-Hispanic Black infants com-
ared to non-Hispanic White infants [11,40].
Although most studies have not conclusively identiﬁed any dis-
inct seasonality of intussusception [9,10,16,18,40,42], we found
 signiﬁcant seasonal trend with a higher incidence in winter
December–February) and a peak in spring (March–May). In the UK
nd other European countries, the season of rotavirus gastroenteri-
is extends from December to April with a peak incidence between
anuary and March [43] including the spring (March–May) quar-
er [44]. Based on these studies, there appears to be an overlap
n our ﬁnding of seasonality (of intussusception) and rotavirus
astroenteritis in the UK. This ﬁnding however needs to be fur-
her explored since no particular association has been observed
etween the inconsistent seasonal pattern of intussusception and
istinct seasonality of rotavirus infections [16,17,45–47].
Our estimated incidence for England was less than half of that
66/100,000 infants) seen in the previous English study [29]. In
ddition to possible reporting differences such as duplicates, cod-
ng errors might explain the higher rate estimated in the previous
tudy, which used routinely collected data (for England). However,
he previous study was carried out in 1993–1995, and an actual
ecline in rates among UK and Irish infants may  have occurred since
hen – a ﬁnding that has been seen in other countries [11,17,39].This  study provides National UK and Republic of Ireland pre-
accination rates of intussusception using prospective, active
urveillance with a standard case deﬁnition. While underreport-
ng is a potential limitation to active surveillance systems, the
[ (2013) 4098– 4102 4101
participation  rate of the BPSU reporting scheme has been shown
to  be about 94% with at least 89% regional coverage [48]. Although
paediatric surgeons were involved for the ﬁrst time in our study,
facilitative methods to achieve maximum case reporting were used
such as: hospital visits introducing the study methodology, identi-
ﬁcation of hospital ‘study-leads’ to review cases and identify those
that had been missed, reminder letters sent with study question-
naires including self-addressed envelopes and liaison with hospital
staff. Such strategies have been shown to be effective in increasing
response rates to postal questionnaires [49].
In order to evaluate the completeness of the established BPSU
active surveillance system for intussusception in the UK, we aim
to compare our study results with routinely collected hospital data
(on intussusception) for England.
In conclusion, with the imminent introduction of the rotavirus
vaccine in the UK, these baseline rates of intussusception are now
available to inform vaccine-safety policy by enabling comparison
with post-introduction incidence.
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